611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
U.S. Task Force Updates Breast Cancer Gene Testing RecommendationsNew Treatments Could Be Powerful Weapons Against Brain TumorsAmerica's Obesity Epidemic May Mean Some Cancers Are Striking SoonerAre You Still Putting Off Colon Cancer Screening?New Study Finds a Family Risk for Blood CancerNew DNA Blood Test May Help Guide Breast Cancer TreatmentDespite Cancer Screening, 'Oldest Old' Have Low Survival Odds: StudyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysAHA News: Common Prostate Cancer Treatment May Increase Risk of Fatal Heart ConditionFinances Affect Women's Choice of Breast Cancer Treatment: StudyDrug Duo May Be an Advance Against a Common LeukemiaVitamin A Linked to Lower Odds of Common Skin CancerChildhood Cancer Steals Over 11 Million Years of Healthy Life: StudySome of Most Common, Deadly Cancers Get the Least Research MoneyBreast Implants Tied to Rare Cancer RecalledNew Test Can Pinpoint Which Pancreatic Cysts Might Turn CancerousCan a Broken Heart Contribute to Cancer?Hurricanes Can Hurt Survival Odds Among Those With CancerNewer Lung Cancer Screening Saves More LivesSugary Sodas, Juices Tied to Higher Cancer RiskHormone Treatment for Prostate Cancer Linked to Heightened Alzheimer's RiskMillions of Life Years, Billions of Dollars Lost to Cancer Each YearMS Linked to Higher Cancer RiskCancer Risk Rises After Iodine Rx for Overactive Thyroid: StudyEarly Risers May Be a Little Less Likely to Get Breast CancerHPV Vaccine Making Headway Against Cancer-Causing Virus WorldwideNew Urine Test Might Show Whether Prostate Cancer Needs Treatment9/11 Dust Linked to Prostate Cancer in First RespondersBetter Treatments Needed to Boost Brain Cancer Survival: StudyCancer Survivors May Have Lower Odds for DementiaHeart Disease Is Lasting Threat to Breast Cancer SurvivorsHow Do Birth Defects Affect Childhood Cancer Risk?More Than 5 Million U.S. Cancer Survivors Deal With Chronic PainStatins May Lower Risk of Stroke After Cancer RadiotherapyYogurt Might Help Men Avoid Colon Cancer: StudyMany Advanced Colon Cancers Were 'Born' Ready to Spread'Double-Edged Sword': Lung Cancer Radiation Rx May Raise Heart Attack RiskYour Drinking Water May Harbor Cancer-Causing Nitrate: StudyNo Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in BloodChemoimmunotherapy Regimen Approved to Treat DLBCLCancer Survivors Predicted to Top 22 Million by 2030Guard Your Skin Against the Summer Sun'Focused' Radiation Could Lighten Treatment Burden for Early Breast Cancer1 in 4 Cancer Survivors Faces 'Financial Hardship' Due to Medical CostsFew Prostate Cancer Patients Are Getting Checkups They NeedTesticular Cancer Treatment Unlikely to Trigger Birth DefectsIs MRI Screening Worth It for Breast Cancer Survivors?Obamacare May Have Helped Close 'Race Gap' in Cancer CareObamacare May Have Boosted Fight Against Ovarian CancerCould 2 Prostate Cancer Drugs Fight Disease in Earlier Stages?
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Trans Women Have Raised Odds of Breast Cancer, But Risk Still Small: Study

HealthDay News
by -- Robert Preidt
Updated: May 15th 2019

new article illustration

WEDNESDAY, May 15, 2019 (HealthDay News) -- Transgender women on gender-confirming hormone therapy have increased odds of breast cancer, but the overall risk is low and not as high as it is for the general female population, a new study finds.

Trans women are those who were declared male at birth but identify as female.

Previous research has shown that hormone replacement therapy (HRT) increases breast cancer risk in postmenopausal women, but it was unclear whether the same was true for trans women receiving hormone treatment.

The new study looked at 2,260 trans women and 1,229 trans men who received gender-affirming hormone therapy at a clinic in the Netherlands between 1972 and 2016.

The researchers found that trans women on hormone therapy had a higher breast cancer risk than the general male population. And transgender men (female sex assigned at birth, male gender identity) were found to have a lower breast cancer risk than the general female population.

Average age at the start of hormone treatment was 31 for trans women and 23 for trans men, and average treatment time was 13 years for trans women and eight years for trans men, according to the report.

Among the trans women, 15 cases of invasive breast cancer were diagnosed at an average age of 50. On average, those patients had received hormone treatment for 18 years.

That rate was higher than that in the overall male population but lower than the general female population, according to the study published May 14 in the BMJ.

Among the trans men, four cases of invasive breast cancer were identified. The patients' average age was 47, and they had 15 years of hormone treatment, on average. That rate was lower than in the general female population.

The results show that the overall risk of breast cancer in transgender people is low, so current screening guidelines are sufficient for those on hormone therapy, according to the study authors.

The researchers were led by Martin den Heijer, of the department of internal medicine/endocrinology at University Medical Center in Amsterdam.

The researchers pointed out that breast cancer risk among trans women rose after a relatively short period of hormone treatment. "It would be worthwhile for future studies to investigate in more detail the cause of breast cancer in transgender people receiving hormone treatment," the authors concluded in a journal news release.

Because this was an observational study, it cannot prove cause and effect. In addition, the researchers noted some limitations of the study, including missing or incomplete data about type of hormone use, family history, genetic mutations, tobacco and alcohol use, and body mass index.

More information

The University of California, San Francisco Transgender Care has more on hormone therapy.